Merck & Co Unusual Options Activity - Merck & Co (NYSE:MRK)

Core Insights - High-rolling investors are bullish on Merck & Co (NYSE:MRK), indicating potential privileged information influencing their trading decisions [1] - The sentiment among major traders shows 66% bullish and 11% bearish positions, with a total of $662,901 in call options and $292,250 in put options [2] Options Activity - A total of 9 options trades were identified for Merck & Co, with a focus on a price range between $85.0 and $110.0 over the last three months [3] - The mean open interest for Merck & Co options trades today is 7184.25, with a total volume of 2,408.00 [4] Largest Options Trades - Significant trades include a put option with a total trade price of $292.2K and multiple call options with total trade prices ranging from $118.5K to $149.8K [8] Company Overview - Merck & Co produces pharmaceutical products across various therapeutic areas, including cardiometabolic diseases, cancer, and infections, with Keytruda being a major contributor to sales [9] - The company generates 47% of its sales from the US human health sector [9] Analyst Insights - Analysts propose an average target price of $118.4 for Merck & Co, with several maintaining a Buy rating and target prices of $120, while one analyst upgraded the rating to Outperform with a target of $130 [11][12]